<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="84032">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01979549</url>
  </required_header>
  <id_info>
    <org_study_id>AEDUGESSH</org_study_id>
    <nct_id>NCT01979549</nct_id>
  </id_info>
  <brief_title>Adverse Events During Upper Gastrointestinal Endoscopy</brief_title>
  <acronym>AEDUGESSH</acronym>
  <official_title>Adverse Events During Upper Gastrointestinal Endoscopy With and Without Sedation: a Multiple Center Report From Shanghai</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shanghai Pudong New Area People's Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Shanghai Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <authority>China: Ethics Committee</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective is to investigate the adverse events during upper gastrointestinal
      endoscopy with and without sedation in Chinese population
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Adverse events</measure>
    <time_frame>Patients will be followed for the duration of hospital stay, an expected average of 2 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>Investigate the adverse events according to the Adverse event reporting tool of the world SIVA International Sedation Task Force during upper gastrointestinal endoscopy with and without sedation.</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">6000</enrollment>
  <condition>Patients Need Upper Gastrointestinal Endoscopy</condition>
  <condition>Peptic Ulcer</condition>
  <condition>Gastric Cancer</condition>
  <condition>Esophagus Cancer</condition>
  <condition>Oesophagitis</condition>
  <arm_group>
    <arm_group_label>Sedation</arm_group_label>
    <description>patients underwent upper gastrointestinal endoscopy with sedation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-sedation</arm_group_label>
    <description>patients underwent upper gastrointestinal endoscopy without sedation</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who will undergo the upper gastrointestinal endoscopy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients will undergo upper gastrointestinal endoscopy

          -  Age &gt; 18 years old

          -  Signed informed consent form

        Exclusion Criteria:

          -  Pregnant

          -  Allergy to propofol or soybean or albumen
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Diansan Su, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Renji Hospital, School of Medicine, Shanghai Jiaotong University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Diansan Su, Doctor</last_name>
    <phone>0086-21-68383702</phone>
    <email>diansansu@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Xiangrui Wang, Doctor</last_name>
    <phone>0086-21-68383198</phone>
    <email>wangxr2010@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Renji hospital, School of Medicine, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200127</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diansan Su, Doctor</last_name>
      <phone>0086-21-68383702</phone>
      <email>diansansu@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Diansan Su, Doctor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Tongji Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200065</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoqing Zhang, M.S.</last_name>
      <email>xq_820175@163.com</email>
    </contact>
    <investigator>
      <last_name>Xiaoqing Zhang, M.S.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Pudong New Area People's Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>lizhi Li, M.S.</last_name>
      <email>Fmlilizhi@sina.com.cn</email>
    </contact>
    <investigator>
      <last_name>Lizhi Li, M.S.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>November 3, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>RenJi Hospital</investigator_affiliation>
    <investigator_full_name>diansan su</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>Adverse events</keyword>
  <keyword>Upper gastrointestinal endoscopy</keyword>
  <keyword>Sedation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophagitis</mesh_term>
    <mesh_term>Stomach Neoplasms</mesh_term>
    <mesh_term>Peptic Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Esophageal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
